Surfactant protein D (SP-D),
1 is a 43-kDa member of the calcium-dependent host defense "collectin" (collagen-lectin) family of proteins that includes surfactant protein A, serum mannose-binding protein, conglutinin, and bovine serum lectins CL-34 (1) . In the lung, SP-D is synthesized and secreted primarily by type II and other nonciliated bronchiolar respiratory epithelial cells (2) (3) (4) . As a component of the innate immune system, SP-D inhibits the proliferation of Gram-negative bacteria, binds and aggregates a variety of microorganisms including respiratory viruses and fungi, and enhances their presentation to resident phagocytic cells for opsonization and intracellular killing (1, 2, 5-7, 9 -12) . In addition, SP-D influences surfactant homeostasis, reduces alveolar macrophage apoptosis, stimulates a variety of immune cells, and enhances oxygen radical production (13) (14) (15) (16) .
Recent findings, however, implicate SP-D in immunomodulation during inflammation and allergic response. SP-D binds alveolar macrophages and circulating leukocytes (17) and stimulates the migration of human neutrophils, monocytes, and macrophages (18, 19) , influencing recruitment following lung injury and inflammation. SP-D stimulates immune cell activity following exposure to pathogen-associated molecular pattern recognition. Increased expression in the lungs of transgenic mice enhanced host defense function and decreased inflammatory responses following exposure to pulmonary pathogens (7, 9, 20, 21) . Conversely, Sftpd Ϫ/Ϫ mice develop emphysema associated with chronic inflammation (22) and exhibit enhanced inflammatory responses to a variety of stimuli (23) . Thus, SP-D plays a role as a surveillance molecule that facilitates killing and clearance of pathogens, serving to control inflammatory responses.
Despite the important protective roles of SP-D in pulmonary homeostasis, transcriptional regulation of SP-D is poorly understood. Recently, a role for SP-1-like transcription factors has been implicated in regulation of the human SP-D gene (SFTPD) promoter, but the identity of these factors is unknown (24) . AP-1 family members regulate SFTPD promoter activity. JunB and JunD enhanced, whereas c-Jun and c-Fos inhibited, transcription (24) . Mutation of DNA binding sites for forkhead transcription factors FoxA1 and FoxA2 decreased transcription of SFTPD. In contrast, TTF-1 did not activate its expression in H441 cells in vitro (24) .
SP-D expression is developmentally regulated and increases dramatically prior to birth. In mouse and rat lung, SP-D mRNA is first detected at midgestation and increases abruptly before birth and during the immediate postnatal period (25) (26) (27) . Glucocorticoid treatment in utero precociously increased SP-D mRNA and accelerated lung maturation. Whereas the mechanism of SP-D induction is not known, it has been suggested that dexamethasone treatment increases promoter occupancy of CCAAT enhancer-binding protein-␤ (C/EBP-␤) (24, 28) . Retinoblastoma protein stimulated SFTPD activation by directly forming a complex with C/EBPs bound to the NF-IL-6 (C/ EBP-␤) consensus site in the SFTPD promoter. Cotransfection of C/EBP-␣, -␤, and -␦ cDNAs increased transcription of the human SFTPD gene in H441 cells (29) .
Following a variety of lung infection and injury, an acute phase response similar to that of liver is observed in the lung (4) . For example, haptoglobin, C-reactive protein, serum lipopolysaccharide-binding protein, and respiratory epithelial derived fibrinogen and ␣ 1 -acid glycoprotein increased following lung injury (29 -33) . SP-D mRNA and protein in lung lavage increased within 6 h after endotracheal endotoxin treatment in rats (32) , following Pseudomonas infection in mice (34) , a brief O 2 exposure to rats (35) , and treatment of type II cells with FGF-7 (36) . SP-D mRNA was markedly increased following exposure to IL-4 and IL-13 in vivo (34, 37, 38) . These observations and other data support the concept that SP-D is rapidly induced following lung injury, perhaps serving a protective role by modulating inflammation and enhancing host defense. Strikingly, Sftpd proximal promoter revealed cis-elements for C/EBPs, nuclear factor of activated T cells (NFAT), AP-1, and the signal transducers and activators of transcription family of transcription factors that are known to rapidly activate transcription of a large number of genes during an effective immune response in several organs (39 -41) . In addition, several TTF-1 sites were identified that may play critical roles in SP-D transcription following lung injury (42) .
Since, SP-D expression is induced following lung injury and exposure to IL-4 and IL-13, we speculated that the calcineurin pathway, known to regulate T cell activation (43) mediated by dephosphorylation of NFATs, may be operative in the regulation of SP-D expression. Calcineurin is a heterodimeric Ca 2ϩ / calmodulin-dependent protein phosphatase activated by calcium ionophores such as ionomycin and inhibited by cyclosporin and tacrolimus (FK-506). It consists of one catalytic (CnA) and one regulatory (CnB) subunit (44) . Changes in expression of cytokines and other immunomodulatory molecules activate T-cell receptors, increasing intracellular calcium concentrations, activating calcineurin. Once activated, calcineurin dephosphorylates NFAT and translocates them into the nucleus. NFATs bind cooperatively with other nucleoproteins to promoters of target genes to induce transcription (41, 45) .
In the present work, we identified an endogenous, calcineurin/NFAT pathway in respiratory epithelial cells of the lung that assembles NFATs, AP-1, and TTF-1 on a proximal enhancer located in the 5Ј-region of the Sftpd gene, forming a multiprotein transcription complex inducing SP-D expression.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Mutagenesis-Sftpd promoter-reporter constructs were made in pGL3-basic vector, a luciferase reporter plasmid (Promega). Using TRANSFEC (Biobase; Biologische Datenbanken GmbH, Wolfenbü ttel, Germany), a promoter sequence analysis and data base program, the Sftpd promoter was identified from a 5.7-kb Sftpd genomic clone (a kind gift from Dr. T. Korfhagen, Cincinnati Children's Hospital, Cincinnati, OH) that contained a 3-kb sequence upstream of the first exon that included a consensus TATA box. A 679-bp BtgI fragment (ϩ79 to Ϫ600 bp) was Klenow end-filled and cloned into the SmaI site of pGL3-basic, the correct orientation was determined, and it was used to generate a series of promoter deletion mutants by PCR cloning bp ϩ79 to Ϫ557, Ϫ357, Ϫ246, Ϫ167, and Ϫ82 into NheI and XhoI sites of pGL3-basic (see Table I for primers used). Rat TTF-1 expression plasmid pRC-CMV-TTF-1 was provided by Dr. R. DiLauro (Naples, Italy). Full-length human NFATc3 (the original clone from Nakoi Aroi), NFATc4 with a 3.1-kb cDNA containing the ORF cloned in the KpnI and NotI site in expression vector pREp4, constitutively active (CA) CA-NFATc3 and CA-NFATc4 in pAC-CMV pLpA-5ϩ expression vector, and constitutively active calcineurin (pECE-FLAG⌬CnA) were provided by Dr. J. Molkentin (Cincinnati Children's Hospital, Cincinnati, OH). Green fluorescent protein (GFP)-VIVIT expression plasmid containing an in-frame ORF for peptide sequence MAGPHPVIVITGPHEE fused to enhanced green fluorescent protein in pEGFP.N1 (Clontech), was a kind gift from Dr. A. Rao (Harvard University, Boston, MA). pcDNA3.1 with CMV promoter (Invitrogen) and pCMV ␤-galactosidase (Clontech) vectors were used to normalize DNA and transfection efficiency, respectively. All subcloned DNAs were confirmed by sequencing.
Cell Culture, Transfection, and Reporter Gene Assays-HeLa cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) with 10% fetal bovine serum. Mouse lung epithelial cells, MLE-15, an immortalized mouse lung epithelial cell line that maintains some morphological and functional characteristics of type II epithelial cells, were cultured in HITES medium (46) for functional characterization of Sftpd promoter. A series of Sftpd promoter-luciferase constructs were used in transient transfection assays using Fugene 6 at a DNA/Fugene ratio of 1:2 according to the manufacturer's instructions (Roche Applied Science). Briefly, 6-well plates at 30 -50% confluence were transfected with a fixed amount of Sftpd promoter-luciferase plasmid and various amounts of CMV-based cDNA expressing transactivator plasmids. For co-transfection experiments, the promoter-reporter plasmid was kept at 15 ng/well unless stated otherwise. Total DNA was normalized with corresponding CMV-empty vectors, and transfection efficiency was normalized to ␤-galactosidase activity using 100 ng/well of pCMV ␤-galactosidase. Two days after transfection, luciferase and ␤-galactosidase assays were performed using 20 l of the supernatant according to a previous protocol (47 in a T75 flask to 80% confluence were washed and suspended in 10 ml of phosphate-buffered saline. 2.5 ml of cells were pelleted at 3,000 rpm and lysed in 0.5 ml of 1ϫ RNA lysis buffer (50 mM Tris⅐Cl, pH 7.5, 50 mM NaCl, 5 mM EDTA, 0.5% SDS) by 2 min of vigorous vortexing. Total RNA was extracted in 100 l of 5 M ammonium acetate (Ambion), 2 l of glycogen and 600 l of acid phenol/ chloroform (5:1) solution, pH 4.5 (Ambion), precipitated in 2 volumes of ethanol, washed in 70% ethanol, dried, and suspended in 60 l of diethyl pyrocarbonate-treated H 2 O. 10 l of RNA suspension was reverse transcribed for first strand cDNA synthesis using SuperScript II-RT, with procedures provided by the manufacturer (Invitrogen). RNA from purified mouse alveolar epithelial type II cells (AE II) was kindly provided by Dr. John Shannon (Cincinnati Children's Hospital, Cincinnati, OH). AE II cells were prepared from 6-week-old female C57B/6 mice as described previously (48) . RT products were produced by PCR using primers described in Table I . Primers and reaction conditions were optimized using cDNA made from reverse transcribed total RNA of adult mouse lung. In studies of mouse alveolar type II cells (AE II cells), PCR was performed on RT product using Amplitaq Gold DNA polymerase (Roche Applied Science) under the following conditions: 95°C for 10 min for the denaturation cycle and 35 cycles at 95°C (30 s), 58°C (30 s) annealing, and 72°C for extension, with a final extension of 10 min at 72°C. ␤-Actin was used as a positive control. Reactions containing RNA that was not reverse transcribed were used as a control to detect genomic DNA contamination.
Immunohistochemistry of Embryonic and Adult Lungs-Embryos were obtained at different gestational stages, processed according to previous methods (49) , and embedded in paraffin. For adult lung tissues, lungs were inflation fixed with 4% paraformaldehyde at 25-cm water pressure and processed for paraffin embedding. Serial 5-m sections were prepared for adult lung. For fetal lung, whole embryos were fixed with 4% paraformaldehyde and sectioned at 5-m intervals. To detect the regulatory subunit calcineurin B1 (CnB1), anti-mouse CnB1 rabbit polyclonal antitibody (PA3-025; Affinity Bioreagents, Goldon, CO) at a 1:500 dilution as primary antibody and anti-rabbit IgG made in goat as secondary antibody (Vector Laboratories, Inc.) were used, respectively, for immunohistochemistry as described previously (50) . Biotinylated secondary antibodies and a streptavidin-biotin-peroxidase detection system (Vector Laboratories) were used to localize the antibody-antigen complexes in the tissues, as previously described (51) . A mouse-on-mouse blocking kit (Vector Laboratories) was used with primary mouse monoclonal antibodies for NFATc3, (F-1, SC-8405X) at 1:100 dilution. Antigen detection was enhanced with nickel-diaminobenzidine and Tris-cobalt, followed by counterstaining with Nuclear Fast Red.
Electrophoretic Mobility Shift Assays (EMSAs)-Nuclear extract from MLE-15 cells were prepared as previously described (52) except that nuclear extracts were stored before dialyses. 32 P-Labeled doublestranded DNA probes were made by a Klenow end-filling reaction using [␣-32 P]dCTP. EMSAs were performed by incubating 10 nM doublestranded DNA oligonucleotide probes corresponding to the Ϫ130 (NFAT-I) and Ϫ170 (NFAT-II) sites (see Table I for oligonucleotide sequences) with 3.5 l (ϳ15 g) of nuclear extract for 40 min at 4°C in 30 l of binding buffer (15 mM HEPES, 0.1 mM EDTA, 0.5 mM dithiothreitol, 40 mM KCl, 5% glycerol, pH 7.9) with 1 g of poly(dI)⅐poly(dC) (Amersham Biosciences), and reactions were electrophoresed on a 4%, 0.5ϫ TBE native polyacrylamide gel at room temperature for 2-3 h at 150 V. Unlabeled competitor double-stranded DNA oligonucleotides, NFAT-I and NFAT-II from the Sftpd promoter, TTF-1 (Oligo-C), with a strong TTF-1 binding site from the rat thyroglobulin gene (rTg) promoter spanning Ϫ82 to Ϫ56 bp (53) , and a strong NFAT site-containing oligonucleotide from the IL-2 promoter (54) were added at a 100-fold molar excess. Antibody supershift assays were carried out in the same buffer by the further addition of 2 and 4 l of either anti-NFATc3 antibodies (SC-1152X; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or albumin as mock, and the reaction continued at 4°C for 1 h. Gels were autoradiographed to detect specific DNA-protein complex formation.
DNase I Footprinting-DNA fragment spanning the Ϫ246 to ϩ79 bp region of the Sftpd promoter was subjected to DNase I reaction (see Fig.  4B ) using MLE-15 nuclear extracts. The (TG) n region in the Ϫ246/ϩ79 Sftpd promoter had four nucleotides (ACAC) less than the original promoter (GenBank TM accession number AF047742) as confirmed by sequencing. The Sftpd promoter (Ϫ246/ϩ79) cloned in pGL3 was digested with NheI and labeled at the 3Ј-end using [␣-
32 P]dCTP (6,000 Ci/mmol) in a Klenow reaction, DNA-purified, and released with XhoI. The DNase I footprinting assay contained 10 fmol (ϳ5,000 cpm) of the end-labeled fragment in 200 l of 1ϫ binding buffer (52) containing 150-and 300-g nuclear extracts, and a protein binding reaction was carried out for 30 min at 4°C. DNase I reaction conditions and purification of digested DNA were as described previously (52) . Samples were heatdenatured and loaded on to an 8% sequencing gel. DNA ladders for G and A ϩ G were made by Maxam-Gilbert chemical sequencing.
Glutathione S-Transferase GST Pull-down Assays-Full-length GST-TTF-1 fusion protein was made in two steps. TTF-1 cDNA was first PCR-amplified with a stop codon from pRC-CMV-TTF-1, digested, and subcloned into EcoRI and HindIII sites (see Table I for primer details) within the multiple cloning sites of pCMV-Tag 2A vector (Clontech, Palo Alto, CA). TTF-1 cDNA was then excised from pCMV-Tag 2A with EcoRI and SalI and ligated in frame between the same enzyme sites in pGEX-4T-3, a bacterial expression vector (Amersham Biosciences), and sequenced. The GST-TTF-1 deletion constructs were made from a series of pVP16-TTF-1 plasmids (47) . DNA fragments containing TTF-1 deletion derivatives were digested with XbaI and Klenow end-filled before cutting with BamHI. The DNA fragments were then subcloned into the BamHI and SmaI sites in pGEX-5X-2, a bacterial expression vector (Amersham Biosciences). The plasmids were transformed into BL21-DE3 bacterial strains for protein expression. GST fusion protein expression, cell lysis, and immobilization of proteins on glutathione-Sepharose beads were performed as described previously (55) . Immobilized proteins were detected on a Tris-glycine 10 -20% SDS-polyacrylamide gel by Coomassie staining and total proteinnormalized for protein-protein interaction using empty glutathioneSepharose-beads. Beads (20 l) with immobilized proteins were washed several times with 1ϫ phosphate-buffered saline, pH 7.4, incubated for 2 h at 4°C with 15 l of in vitro transcribed and translated radiolabeled [ 35 S]Met-CA-NFATc3 in 1 volume binding buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 100 mM NaCl and 0.1% Nonidet P-40) on a rotator. Beads were washed three times with 1.5 ml of wash buffer (same as binding buffer) and boiled in 1 volume of SDS Laemmli buffer containing 10% ␤-mercaptoethanol. Proteins released were separated by electrophoresis under reducing conditions on SDS 10 -20% Tris-glycine polyacrylamide gradient gel (Novex, San Diego, CA). Gels were dried, and radiolabeled [
35 S]Met-CA-NFATc3 was detected on a PhosphorImager (Storm 860; Amersham Biosciences).
Co-Immunoprecipitation Assays and Western Blotting-The 3ϫ FLAG-tagged CA-NFATc3 expression vector used in the co-immunoprecipitation experiment was constructed as follows. CA-NFATc3 in pAC-CMV pLpA-5ϩ expression vector was digested with HindIII and Klenow end-filled and then excised with NotI containing the SV40 3Ј-untranslated region and inserted into EcoRV and NotI sites of 3ϫ FLAG-CMV expression vector. The 3ϫ FLAG-tagged CA-NFATc3 vector was transfected (50 g) into 40% confluent MLE-15 cells in T75 flask, and nuclear extracts were prepared after 48 h as described (56) , except that nuclear proteins were extracted by suspending nuclei for 1 h in 1 volume of high salt extraction buffer (20 mM HEPES, pH 7.9, 550 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, and 10 mM phenylmethylsulfonyl fluoride) with one protease inhibitor minitablet (Roche Applied Science). Nuclear extracts from MLE-15 cells (ϳ15 g/l) were diluted in 10 volumes of 1ϫ phosphate-buffered saline and incubated for 2 h on a rotator at 4°C with 100 l of mouse monoclonal anti-FLAG M2-IgG-tagged Sepharose beads (Sigma). The beads were washed three times with 1.5 ml of wash buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 100 mM NaCl, and 0.1% Nonidet P-40) and boiled in 1 volume of SDS buffer (Laemmli sample buffer) containing 10% ␤-mercaptoethanol. The co-immunoprecipitated proteins released were separated by electrophoresis under reducing conditions on SDS-10Ϫ20% Tricine polyacrylamide gradient gels (Novex) and transferred to nylon membranes (Bio-Rad). Protein blots were blocked with 5% nonfat dry milk in TBST (10 mM Tris, pH 8, 150 mM NaCl, 0.1% Tween 20) and incubated with anti-TTF-1 monoclonal antibody produced in our laboratory, followed by horseradish peroxidase-conjugated rabbit anti-mouse IgG (Calbiochem). The presence of FLAG-tagged CA-NFATc3 on beads was assessed using primary anti-FLAG mouse monoclonal antibodies directly conjugated to horseradish peroxidase (Sigma). Western blots were developed with the enhanced chemiluminescence system (Amersham Biosciences) and exposed to autoradiographic film X-Omat (Eastman Kodak Co.).
RESULTS

TTF-1 and NFATs Activate Transcription from the Sftpd
Promoter-A promoter-luciferase reporter plasmid (Fig. 1A) comprising Ϫ600 to ϩ79 bp (D-600-Luc) of the mouse surfactant protein D gene (Sftpd), was transiently transfected into HeLa and MLE-15 cells. The Ϫ600/ϩ79 bp Sftpd promoter was highly active in MLE-15 but not in HeLa cells (Fig. 1B) . HeLa cells co-transfected with D-600-Luc and increasing amounts of an expression plasmid encoding TTF-1 activated the Sftpd promoter by ϳ15-fold (Fig. 1C) . The proximal region of the Sftpd promoter contains consensus elements for both TTF-1 and NFATs. We therefore hypothesized that TTF-1-and NFATdependent pathways may directly influence Sftpd promoter activity in respiratory epithelial cells. Full-length NFATc3 (FuNFATc3), full-length NFATc4 (Fu-NFATc4), constitutively active NFATc3 (CA-NFATc3), or constitutively active NFATc4 (CA-NFATc4) expression plasmids (Fig. 1D) activated Sftpd promoter activity in MLE-15 cells. CA-NFATc3 was more active than CA-NFATc4 (Fig. 1D, lanes 4 and 5) . Full-length NFATs Fu-NFATc3 and Fu-NFATc4 also activated the Ϫ600/ ϩ79 Sftpd promoter, albeit to a much lesser extent (Fig. 1D,  lanes 2 and 3) , suggesting endogenous but weak calcineurin activity in respiratory epithelial cells. Interestingly, this NFAT activation was not observed in HeLa cells (data not shown), suggesting the requirement of cofactors present in MLE-15 cells but not in HeLa cells.
NFATs Are Present in the Respiratory Epithelial CellsSince NFATs activated the Ϫ600/ϩ79 Sftpd promoter in MLE-15 cells, we tested whether NFATs were expressed in MLE-15 and alveolar epithelial type II cells (AE-II) that are known to express SP-D (27, 57) . RT-PCR was carried out using total RNA from MLE-15 and purified mouse AE-II cells. Unique sets of primers designed for murine NFATc1, NFATc2, NFATc3, NFATc4, and NFATc5 cDNA (Table I) gave PCR products of expected sizes ( Fig. 2A) . The expression profiles of NFATs were similar in MLE-15 and AE-II cells. NFATc1 and NFATc3 were the predominant forms (Fig. 2, lanes 2, 4, 8 , and 10), NFATc4 was weakly expressed in AE-II cells (Fig. 2, lanes  5 and 11) , whereas NFATc2 was not expressed in either cell type (Fig. 2, lanes 3 and 9) . NFATc5, a ubiquitously expressed gene not part of the classical NFAT family (58) , was detected at low levels in MLE-15 and AE-II cells (Fig. 2, lanes 6 and 12) .
NFAT Binds Sftpd Promoter Elements-Since NFATc3 was most active on Ϫ600/ϩ79 Sftpd promoter and was expressed at high levels in MLE-15 and AE-II cells, we tested whether NFATc3 directly bound to the Ϫ600/ϩ79 Sftpd promoter. Two perfect NFAT consensus sites (NFAT-I and NFAT-II) (Fig. 3B ) present in the Sftpd promoter region at Ϫ170 to Ϫ164 and Ϫ130 to Ϫ124 bp from the transcription start site with a core similarity of 1.0 and a matrix similarity of 0.99 and 0.97, respectively, were identified using MatInspector 7.0 (Genomatix Software GmbH, Mü nchen, Germany). Two DNA probes comprising NFAT-I or NFAT-II (see Table I ) were used in EMSAs with nuclear extracts made from MLE-15 cells transfected with CA-NFATc3 plasmid. NFAT-I and NFAT-II probes formed strong DNA-protein complexes of similar size from MLE-15 nuclear extracts (Fig. 2B, lanes 2 and 7) and were competed by 100-fold excess of unlabeled self-DNA (Fig. 2B,  lane 3 and 8) but not by 100-fold excess of TTF-1 (Oligo-C) consensus probe (Fig. 2B, lanes 4 and 9) designed from the rat thyroglobulin promoter (53) , indicating that the protein bound specifically to NFAT sites. When a strong NFAT site probe derived from the IL-2 promoter (54) was used for competition, the DNA-protein complex could not be seen for both sites (Fig.  2B, lanes 5 and 10) , further suggesting that the two NFAT sites found in the Ϫ600/ϩ79 Sftpd promoter bound NFATs. To establish that nuclear proteins from MLE-15 cells indeed bound NFATc3 to the two NFAT sites, gel supershift experiments were carried out. Antibodies to NFATc3 supershifted DNAprotein complexes formed on NFAT-I and NFAT-II sites (Fig.  2C, lanes 3, 4, 8, and 9) , whereas there was no change in the mobility of the complexes in the presence of bovine serum albumin. To further demonstrate that nuclear proteins from MLE-15 cells bound NFAT sites in the context of the native promoter, DNase I protection assays were carried out on the Ϫ246/ϩ79 Sftpd fragment. Strong DNase I protection regions spanning two NFAT sites, NFAT-I and NFAT-II (Fig. 4A) , and AP-1, TTF-1, and C/EBP sites were identified as part of the protected or hypersensitive region (Fig. 4A) . The region near TTF-1 binding site was hypersensitive to DNase I at low nuclear protein concentrations (Fig. 4A, lane 4) , whereas the region around the AP-1 site showed increased DNase I protection in contrast to the hypersensitivity found on naked DNA. Changes in DNase I hypersensitivity were observed 3Ј to the NFAT-II site (Fig. 4A, open boxes) . Such changes in DNase I digestion patterns are a hallmark for the formation of specific DNA-protein complexes that induce DNA distortions leading to altered DNase I sensitivity (59), suggesting a possible multiprotein complex binding at the area of DNase I protection that may comprise NFAT, TTF-1, AP-1, and other factors.
Expression of NFATc3 and Calcineurin in the Lung Epithelium-Since TTF-1 is strictly expressed in the respiratory epithelium, it was relevant to test the expression of NFATc3 to determine whether TTF-1 and NFATc3 are co-expressed. Expression of calcineurin, a phosphatase that activates NFATs, was also assessed. NFATc3 and CnB1 were detected by immunostaining (Fig. 3) . Calcineurin was detected in the cytoplasm at apical and basal regions of respiratory epithelial cells in conducting airways and peripheral regions of the lung at embryonic days 15.5-17.5. The intensity of staining was highest in the peripheral lung (Fig. 3A) . CnB1 was also detected in the respiratory epithelium of the adult lung, wherein intense nuclear staining was noted in the bronchiolar region. (Fig. 3, B 
FIG. 2. NFATs in the respiratory epithelial cells.
A, mRNA expression of NFAT genes in the respiratory epithelial cells. RT-PCR was performed on total RNA isolated from purified mouse alveolar epithelial type II (AE II) and MLE-15 cells. Unique sets of primer pairs were used to identify expression of each NFAT gene, c1, c2, c3, c4, and c5 (see Table I ). NFATc1 and NFATc3 were expressed at high levels (lanes 2, 4, 8, and 10) in MLE-15 and alveolar epithelial type II cells. DNA molecular weight markers from 100 to 500 bp (lane 1, M) were used to identify correct PCR product sizes for expression of each NFAT gene. ␤-Actin mRNA was amplified as a positive control (lanes 7 and 13) . B, EMSAs revealed NFATc3 binding to proximal Sftpd promoter elements. 32 P-Labeled double-stranded oligonucleotides (10 nM) derived from NFAT-I (Ϫ170/Ϫ164) and NFAT-II (Ϫ130/Ϫ124 bp) sites on the Sftpd gene were used for EMSAs (see Table I ). Nuclear extracts made from MLE-15 cells transfected with NFATc3 expression vector were incubated with labeled probes. Both probes formed DNA-protein complexes of similar size as shown by the solid arrow (lanes 2 and 7) . These DNA-protein complexes were abolished by 100-fold excess of unlabeled self-DNA probes (lanes 3 and 8) but not by a 100-fold excess of TTF-1 (Oligo-C) consensus probe (lanes 4 and 9) . In contrast, a 100-fold excess of unlabeled NFAT site probe derived from human IL-2 promoter competed with NFAT-I and NFAT-II probes leading to loss of the DNA-protein complexes (lanes 5 and 10) . Thus, specific protein complexes were identified at regions overlapping NFAT sites. C, protein complexes formed on NFAT-I and NFAT-II site oligonucleotides (lanes 2 and 7) were supershifted by NFATc3 antibody (lanes 3 and 4 and lanes 7 and 8) . Note the decrease in intensity of DNA-protein complex (solid arrow) and the formation of a higher molecular weight complex in the presence of NFATc3 antibody (open arrow). Bovine serum albumin did not alter the complex (lanes 5 and 10) . and C). Staining was also detected in endothelial cells of the pulmonary vasculature. At embryonic day 15.5, NFATc3 was present in the apical regions of the epithelial cells (Fig. 3D) . In contrast, at embryonic day 17.5 and in the adult lung epithelium, NFATc3 became localized to the nuclei of bronchiolar cells (Fig. 3, E and F) . Thus, calcineurin, NFATc3, and SP-D (27) are co-expressed in respiratory epithelial cells during lung morphogenesis and in the adult. Calcineurin-responsive Enhancer in the Sftpd Promoter-NFAT activation and its subsequent binding to promoter elements are dependent upon its dephosphorylation by calcineurin. Therefore, the role of calcineurin in modulating Sftpd promoter activity was investigated in MLE-15 cells transfected with a proximal promoter-reporter construct (D-246-Luc) containing the two NFAT sites (Fig. 4, C and D) . Treatment with ionomycin, a calcineurin activator, or ionomycin and phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator that activates AP-1 family members and synergizes with NFATs (43) 5,  open box) . Naked DNA was treated with DNase I as a control (lanes 3 and 6) . G and A ϩ G DNA ladders were used as markers (lanes 1, 2, and  7) . Solid boxes represent DNase I footprinted regions, and open boxes show changes in DNase I hypersensitivity (decrease (HS) and increase (HSЈ) in DNase I hypersensitivity) after incubation with MLE-15 nuclear extracts. B, Sftpd promoter fragment spanning Ϫ200 to ϩ1 bp showing DNase I footprinted regions (solid bars). C, schematic representation of the putative transcription factor binding sites and other features of the Sftpd promoter relevant to this study. Note the purine-pyrimidine (TG) n stretch adjacent to the region that binds a number of protein complexes as judged by footprinting analysis, including putative binding elements for C/EBP and signal transducers and activators of transcription proteins. D, stimulation of Sftpd promoter activity in the presence of ionomycin and PMA (lanes 2-4) . The D-246-Luc (15 ng) was transfected into MLE-15 cells. 1 M ionomycin (Calbiochem) and 10 nM PMA (Calbiochem) in Me 2 SO were added to HITES medium containing 1 mM CaCl 2 . Cells were harvested after 16 h, and luciferase activity was measured. E, inhibition of Sftpd promoter activity in the presence of cyclosporin (lanes 2-4) . promoter (Fig. 4C, lanes 2 and 3) . Cyclosporin A, an inhibitor of calcineurin, decreased the promoter activity in a dose-dependent manner (Fig. 4D, lanes 2-4) , supporting the concept that calcineurin, via NFATs influenced Sftpd promoter activity. To demonstrate that the calcineurin/NFAT pathway indeed modulated Sftpd transcription by recruiting NFAT proteins to the proximal promoter, deletion constructs of the Sftpd promoter were tested in MLE-15 cells (Fig. 5A) . A proximal enhancer element was identified between Ϫ167 and Ϫ82 bp that contains a purine-pyrimidine stretch (TG) n and a 50-base pair sequence with putative NFAT, AP-1, TTF-1, and C/EBP binding sites that were footprinted (Figs. 4C and 5A ). Despite having an NFAT-II site, the region between Ϫ167 and Ϫ246 repressed the enhancer activity (Fig. 5A) . To identify sequences that confer NFAT-dependent activity, deletion constructs were co-transfected with CA-NFATc3 into MLE-15 cells. The promoter construct Ϫ82/ϩ79 lacking NFAT sites did not respond to NFATc3 (Fig. 5B) , whereas NFATc3 increased activity up to 11-fold for Ϫ167/ϩ79 Sftpd promoter. No further increase in promoter activity was observed in larger promoter constructs (Fig. 5B) , indicating recruitment of NFATs between Ϫ167 and Ϫ82 bp. Thus, excluding the (GT) n repetitive sequence, our data identified a 50-base pair enhancer confined to region Ϫ167/Ϫ117 bp comprising NFAT-I, AP-1, TTF-1, and C/EBP sites. The activity of Ϫ167/ϩ79 Sftpd promoter was entirely dependent upon calcineurin and inactivation of NFATs. For example, fulllength NFATc3 was inactive in the D-167-Luc construct (Fig.  5C, lane 2) , whereas co-expression with constitutively active calcineurin (⌬Cn-A) increased promoter activity up to 10-fold (Fig. 5C, lane 4) . To test whether calcineurin directly increased Sftpd promoter activity utilizing endogenously present NFAT proteins in lung epithelial cells, constitutively active calcineurin (⌬Cn-A) was cotransfected with D-167-Luc in MLE-15 cells. Dose-dependent expression of ⌬Cn-A increased D-167-Luc activity (Fig. 5D, lanes 2-6) . When MLE-15 cells transfected with D-167-Luc were treated with cyclosporin A, a calcineurin inhibitor, a dose-dependent inhibition of promoter activity was observed, demonstrating that Ϫ167/ϩ79 Sftpd promoter activity was directly modulated by endogenous calcineurin (Fig. 5E) .
VIVIT Abolishes the Effects of Calcineurin/NFAT Pathway on the Minimal Sftpd Promoter Activity-A potent NFAT inhibitory peptide VIVIT docks on calcineurin and selectively interferes with the calcineurin-NFAT interaction, leaving its phosphatase activity intact (60) . When plasmid expressing GFP-VIVIT was co-transfected with D-167-Luc, a dose-dependent decrease in the promoter activity was observed (Fig. 6A) , indicating physical interference from GFP-VIVIT peptide on the calcineurin-NFAT interaction. Expression of GFP-VIVIT renders NFATs inactive in the phosphorylated state in the cytoplasm unable to translocate into the nucleus and activate transcription. Thus, activated NFATs are directly required for Sftpd promoter activity. Even in the presence of high levels of constitutively active calcineurin, VIVIT strongly inhibited the enhancer activity (Fig. 6B) , further supporting the concept that activity of the Sftpd promoter requires direct NFAT activation and is not activated by calcineurin pathways independently of NFATs. Taken together, the activity of the proximal Sftpd promoter is modulated by the calcineurin/NFAT pathway in respiratory epithelial cells.
NFATc3 and TTF-1 Physically Interact and Synergistically Activate the Sftpd Promoter-Since the functional NFAT sites are adjacent to the TTF-1 site (Fig. 4B) , functional cooperativity and physical interaction of NFATc3 and TTF-1 proteins on the D-167-Luc proximal enhancer were tested. Unlike D-600m-Luc, NFATc3 activated the Ϫ167/ϩ79 Sftpd promoter in HeLa cells, thus making it amenable for functional studies (Fig. 7A) . CA-NFATc3 increased the activity of the Ϫ167/ϩ79 Sftpd promoter and synergistically enhanced transactivation by TTF-1 in HeLa cells (Fig. 7B) . To demonstrate physical association between NFATc3 and TTF-1 in respiratory epithelial cells, 3ϫ FLAG-tagged CA-NFATc3 protein expressed in MLE-15 cells was immunoprecipitated with anti-FLAG mouse monoclonal antibodies attached to Sepharose beads (Fig. 7C, i) . Co-immunoprecipitation of TTF-1 with FLAG-tagged NFATc3 was confirmed by blotting with mouse monoclonal antibody to TTF-1 (Fig 7C, ii) .
The TTF-1 Homeodomain (HD) Is Required for Direct Physical Interaction with NFATc3-To determine whether direct protein-protein interactions mediated the observed cooperation between TTF-1 and NFATc3, GST pull-down assays were performed with GST fused to full-length TTF-1 (GST-TTF-1) and in vitro transcribed and translated radiolabeled [
35 S]Met-CANFATc3. GST-TTF-1 full-length protein strongly interacted with CA-NFATc3 (Fig. 8A, lanes 2 and 3) , indicating direct physical interaction between TTF-1 and NFATc3 in vitro. To identify the TTF-1 domains involved in physical interaction with NFATc3, a series of GST-TTF-1 protein deletion constructs were made (Fig. 8C ) and incubated with in vitro transcribed and translated radiolabeled [ 35 S]Met-CA-NFATc3. TTF-1 HD (residues 161-223) alone (Fig. 8B, lanes 5 and 6) , TTF-1 HD with the amino-terminal (residues 1-223) region (Fig. 8B, lanes 7 and 8) , and TTF-1 HD with the carboxylterminal (residues 161-372) region (Fig. 8B, lanes 9 and 10) strongly interacted with CA-NFATc3. In contrast, GST-TTF-1 amino-terminal (residues 1-160) region (lanes 3 and 4) and GST-TTF-1 carboxyl-terminal (residues 224 -372) region (lanes 11 and 12), which do not contain the HD, did not bind [
35 S]Met-CA-NFATc3. TTF-1 HD was necessary and sufficient for direct physical interaction with NFATc3, whereas the flanking amino-terminal and carboxyl-terminal activation domains did not physically interact with NFATc3.
DISCUSSION
Expression of SP-D is highly regulated in the respiratory epithelium, increasing prior to birth, following a variety of lung injury, exposure to pathogens, and in response to Th2-cytokines. Transcriptional pathways regulating SP-D expression are largely unknown. In this study, we identified an endogenous calcineurin/NFAT pathway in the respiratory epithelial cells that regulated Sftpd transcription. Calcineurin and NFATc3 co-expressed in the respiratory epithelial cells of the developing and postnatal lung at sites of SP-D expression (27) . A calcineurin-dependent transcriptional enhancer was identified in the proximal Sftpd promoter. This region contained an NFAT⅐AP-1 composite element adjacent to a TTF-1 binding 8) , and TTF-1 HD with the carboxyl-terminal region (lanes 9 and 10) strongly interacted with CA-NFATc3. In contrast, Sepharose beads without GST protein (lanes 1 and 2) , with GST protein alone (lanes 13 and 14) , with the GST-TTF-1 amino-terminal region (lanes 3 and 4) , and with the GST-TTF-1 carboxyl-terminal region (lanes 11 and 12) site. NFAT inhibitory peptide VIVIT (60) abolished the enhancer activity, demonstrating the requirement of activated NFATs to stimulate the Sftpd promoter. TTF-1 and NFATc3 physically interacted and synergistically stimulated the Sftpd promoter activity, supporting the concept that they are a part of a transcription complex regulating Sftpd transcription. A transcriptional pathway mediated by interactions between activated NFATc3 and TTF-1 regulate SP-D expression in the respiratory epithelial cells.
Whereas NFATs were first identified in T-cell development in the immune system, they are expressed in many cell types and contribute to diverse cellular functions (41) . Calcineurin and NFATs have recently been implicated in development and differentiation of the nervous system, bone, cartilage, muscle, heart, skin, and fat tissues (41) . Our studies demonstrate that calcineurin, NFATc3, and SP-D are coincident with TTF-1 protein expression in the respiratory epithelium during fetal lung development. Whereas neither NFATc3 nor TTF-1 expression is confined to the lung during development, these transcription factors are co-expressed in the respiratory cells of the developing lung, where they physically interacted and synergistically activated Sftpd transcription. Consistent with this finding, alveolar epithelial type II cells that co-express TTF-1 and NFATc3 mRNA secrete SP-D protein in culture (48) . The role of TTF-1 and its phosphorylation mediated by several kinases play a critical role in lung development (61, 62) . Thus, disparate signaling events that post-translationally influence TTF-1 and NFATc3 function may converge on target genes to initiate their spatial, temporal, and cell-specific expression. Taken together, our data support the hypothesis that the calcineurin/ NFAT pathway interacts with TTF-1 to regulate SP-D expression.
Although SP-D has been regarded as constitutively expressed (1), recent studies demonstrate activation of SP-D expression following inflammation by exposure to pathogens, allergens, and pollutants (4, 32) . The present study demonstrates that Sftpd promoter is regulated by the calcineurin/NFAT pathway. NFAT activates transcription of a number of genes following an effective immune response (41) . NFAT binds cooperatively with transcription factors of the AP-1 family to composite NFAT⅐AP-1 sites found in the regulatory regions of immunomodulatory genes (43) . Indeed, an NFAT⅐AP-1 composite site in the Sftpd proximal promoter (Ϫ139/Ϫ125) produced DNase I footprints with nuclear proteins from lung epithelial cells and was responsive to ionomycin and PMA, a hallmark of NFAT⅐AP-1 sites that bind activated NFAT and AP-1 family of transcription factors in target genes (41) . Human SFTPD is regulated by AP-1 family members (24) . Because AP-1 activity isalsomodulatedbydiversesignalingpathways(63),NFAT⅐AP-1-dependent transcription may integrate responses to lung injury.
TTF-1 regulates transcription of genes involved in lung morphogenesis and surfactant protein production (64) . TTF-1 synergistically activates transcription of lung surfactant genes and several genes involved in lung development by direct proteinprotein interaction or functional cooperation with a number of transcription factors (47, 65, 66) . For example, TTF-1 interacts with GATA6 to activate SP-C and Wnt7b transcription (47, 67) . Transcriptional co-activator TAZ and NFI interact with TTF-1 and synergistically activate the SP-C gene (65, 68) , whereas surfactant protein A and SP-B transcription is regulated by interaction of TTF-1 with CREB-binding protein and SRC-1 (66, 69) . TTF-1 also interacts with RAR/RXR and BR22 (66, 70) to activate SP-B transcription. TTF-1 is a homeodomain-containing transcription factor. In general, HD proteins have low DNA binding specificity and require partners and co-activators to bind specific regulatory regions of target genes (71) . This inherent flexibility to interact with relevant cofactors allows them to execute precise spatial, temporal, and tissue-specific roles (71) . Our findings demonstrate that TTF-1 acts as a cofactor for NFATc3 and synergistically activates Sftpd transcription. NFAT proteins have relatively low affinity for DNA binding sites (41) . NFAT proteins interact with several families of transcription factors and cooperatively bind DNA as heterodimers on native promoters of target genes and synergize transcription (41) . NFAT⅐AP-1 complexes have discrete and flexible polar patches providing interaction surfaces for binding of different transcription factor (72) . TTF-1-NFAT interactions may be facilitated by the close apposition of the TTF-1 and NFAT binding elements in the Sftpd proximal promoter. TTF-1 HD alone interacted with NFATc3 and was required for protein-protein interaction with NFATc3. Recently, TTF-1 homeodomain interaction with the carboxyl-terminal zinc finger domain of GATA6 synergizing transcription from the Sftpc promoter was demonstrated (47) . Whether GATA6 and NFATc3 interact with the same region of the TTF-1 HD is an interesting question. Nonetheless, transcriptional synergism due to physical interaction of homeodomains with other transcription factors is well documented. For example, Pitx HD interacts with basic helix-loop-helix proteins on the proopiomelanocortin promoter, whereas Pdx1 HD interacts with Pan1 on the rat insulin promoter (8, 73) .
The present study identifies active components of the calcineurin/NFAT pathway in the lung epithelial cells. Calcineurin and NFATc3 are expressed coincidentally with TTF-1 and SP-D in respiratory epithelial cells of the fetal and adult lung. NFATc3 and TTF-1 physically interacted and synergistically activated Sftpd transcription.
